The identified genes included CAP2 (cyclase-associated actin cytoskeleton regulatory protein 2), previously studied as a potential early stage HCC biomarker, and ITGA6, which showed an incremental increase in expression from eHCC [10,11]. The gene discussed is ITGA6; the disease is hepatocellular carcinoma.